Work

Phase 1 clinical trial of losmapimod in facioscapulohumeral dystrophy: Safety, tolerability, pharmacokinetics, and target engagement

Year: 2021

Type: article

Study design: Clinical Trial

Source: British Journal of Clinical Pharmacology

DOI: 10.1111/bcp.14884

Authors: Michelle L. Mellion, Lucienne Ronco, Cecile L. Berends, Lisa Pagan, Sander Brooks, Michiel J. van Esdonk, Emilie M. J. van Brummelen, Adefowope Odueyungbo, Lorin A. Thompson, Michelle Hage, Umesh A. Badrising, Shane Raines, William G. Tracewell, Baziel van Engelen, Diego Cadavid, Geert J. Groeneveld

Institutions: Fulcrum Therapeutics (United States), Centre for Human Drug Research, Leiden University Medical Center, Radboud University Medical Center

Language: English

Topic: Muscle Physiology and Disorders

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3159336201

FWCI: 2.352

Cites: 17

Cited by: 39

Related to: 10